Ex vivo gene therapy of Duchenne muscular dystrophy based on autologous transplantation of genetically modified myoblasts is limited by their premature senescence. MyoD-converted fibroblasts represent an alternative source of myogenic cells. In this study the forced MyoD-dependent conversion of murine NIH-3T3 fibroblasts into myoblasts under the control of an inducible promoter silent in the presence of tetracycline was evaluated. After tetracycline withdrawal this promoter drives the transcription of MyoD in the engineered fibroblasts, inducing their myogenesis and giving rise to β-galactosidase-positive cells. MyoD-expressing fibroblasts withdrew from the cell cycle, but were unable to fuse in vitro into multinucleated myotubes. Five days following implantation of engineered fibroblasts in muscles of C57BL/10J mice we observed a sevenfold increase of β-galactosidase-positive regenerating myofibers in animals not treated with antibiotic compared with treated animals. After 1 week the number of positive fibers decreased and several apoptotic myonuclei were detected. Three weeks following implantation of MyoD-converted fibroblasts in recipient mice, no positive "blue" fiber was observed. Our results suggest that transactivation by tetracycline of MyoD may drive an in vivo myogenic conversion of NIH-3T3 fibroblasts and that, in this experimental setting, apoptosis plays a relevant role in limiting the efficacy of engineered fibroblast transplantation. This work opens the question whether apoptotic phenomena also play a general role as limiting factors of cellmediated gene therapy of inherited muscle disorders.
INTRODUCTION
of the MyoD family (MyoD, Myogenin, MRF4, and Myf-5) are basic helix-loop-helix transcription factors Dystrophin deficiency at the muscle membrane leads able to activate muscle gene expression, suggesting a to Duchenne muscular dystrophy (DMD), a severe mussignificant role in determination and differentiation of cle-wasting disease that is inevitably fatal in early adultskeletal muscle (26, 40) . During muscle development in hood (16) . Transplantation of normal myoblasts into dysvivo, MyoD and Myf-5 are responsible for mediating trophic muscles has been used in DMD with little success primary activation, defining the myoblast state, position- (15, 18, 19, 21) . This limited success may be due to several ing the proper number of cells in the muscle-forming problems, in particular the difficulty of producing large regions of the body, and for receiving inhibitory signals amounts of myoblasts capable of fusion to form new musfrom the environment. Myogenin and MRF4 are acticle fibers and the immune response of the host against the vated by MyoD or Myf-5 and are used for bypassing injected myoblasts. To avoid rejection problems, autolonegative control in vivo, and for activating most downgous transplantation of the patient's corrected myoblasts stream muscle genes by direct interaction with transcriphas been proposed but the low proliferative capacity of tional enhancers (39) . DMD myoblasts limits such procedure.
The forced expression of any of MyoD family genes The four known myogenic regulatory factors (MRF) in nonmuscle cultured cells can convert them to a skele-210 DEL BO ET AL.
tal muscle phenotype. MyoD is able to activate muscle tains a multiple cloning site (MCS) immediately downstream to the P hCMV*-1 promoter. Therefore, any cDNA or gene expression by binding to a specific DNA sequence, called E-box, after heterodimerization with E47 (a myo-gene inserted into one of the sites in the MCS will be responsive to the tTA regulatory protein. Vector pUHD-genesis-related protein) (7) . In the presence of fetal bovine serum (FBS) in proliferative medium, myogenic 15 .1neo contains the tTA regulatory protein under the control of a cytomegalovirus promoter and the gene en-differentiation is inhibited through the intracellular expression of inhibitor of differentiation (Id) proteins.
coding neomycine resistance (41) . Vector pUHC13.3 expresses luciferase gene under the control of the P hCMV*-1 Id protein binds E47, displacing MyoD; if FBS is withdrawn from the medium, E47 is released from Id and is promoter. Plasmids pUHD10.3, pUHD15.1neo, and pUHC13.3 were generous gifts of Prof. H. Bujard (Uni-free to bind MyoD, promoting differentiation (1). MyoDϳE47 is an artificial dimer where MyoD is cova-versitat Heidelberg, Germany). Plasmid pUHD10.3My-oDϳE47 was obtained by inserting a EcoRI/ClaI frag-lently bound to E47 by a tether. This construct is not sensitive to the inhibition induced by the factors present ment encoding MyoDϳE47 tethered dimer from the vector pECEMyoDϳE47 into pUHD10.3 previously lin-in FBS (25). The most evident disadvantage in vitro of the forced MyoD-induced differentiation program is the earized with EcoRI. Vector pMRF4Z contains the regulatory sequences of mouse MRF4 driving the expression irreversible withdrawal from the cell cycle, which limits the absolute quantity of recovered transfected cells. A of E. coli β-galactosidase or lacZ (27). Vector pMRF4(300)Z was constructed as follows: a fragment possible solution to the MyoD-dependent inhibition of proliferation is the utilization of inducible promoters spanning bases −300 to +43 of the upstream region of mouse MRF4 was amplified and gel purified; then the driving the expression of MyoDϳE47 construct.
In the present article, we describe a system that not fragment, containing an engineered BamHI site at its 5′ end and a XhoI site at its 3′ end, was ligated in substitu-only allows differential control of MyoDϳE47 activity but produces a muscle-specific gene expression in a very tion of the original 6.5-kb insert into pMRF4Z. Plasmids pECE MyoDϳE47 and pMRF4Z were kind gifts of Dr. high number of cells starting from nonmuscle cells such as NIH-3T3 mouse fibroblasts. This system makes use Wold. Vector pY3 confers resistance to the toxin hygromycin B (3). The plasmids used for transfections were of a tetracycline-regulated transcriptional activator (tTA) consisting of the E. coli Tn10 tetracycline repressor purified by Plasmid Maxi Kit (Quiagen). (tetR) fused with the transactivation domain of herpes Cell Culture and Transfection simplex virus VP16 protein (12) . The tTA hybrid protein acts as a transcriptional activator only in the absence
The NIH-3T3 Swiss Albino mouse fibroblasts cell line was purchased from the American Type Culture of tetracycline, stimulating a minimal human cytomegalovirus promoter (P hCMV*-1 promoter) fused to tetracy-Collection (Rockville, MD). The growth medium (GM) for the cells was Dulbecco's modified Eagle's medium cline operator sequence (tetO). We set up an in vitro expression system where tetO sequences are followed (DMEM) supplemented with 10% FBS. DMEM supplemented with 5% horse serum was used as differentiation by MyoDϳE47 cDNA; only in the absence of tetracycline was the tTA protein able to bind to the tetO se-medium (DM). For stable and transient transfections cells were quence, promoting the forced transcription of exogenous MyoDϳE47. Therefore, MyoDϳE47 gene expression in seeded at 2.5 × 10 5 on 60-mm tissue culture dishes and transfected 24 h after using standard calcium-phosphate NIH-3T3 stably transfected cells can be repressed during administration of tetracycline, whereas removal of the technique. In the first step cells were transfected with 10 µg of pUHD15.1neo ( Fig. 1 ). Selective medium contain-antibiotic induces in the same cells a myogenic process.
The aim of this work was to investigate the in vitro ing 300 µg/ml geneticin was supplied to the cells 24 h after transfection, and resistant colonies appeared after and in vivo induction of forced myogenesis in a tetracycline-dependent manner, the long-term survival of the 15-20 days. Isolated colonies were picked, transferred to multiwell plates, and expanded. The levels of activity system, and the feasibility to obtain an infinite number of cells able to produce a muscle-specific gene expres-of tTA were analyzed in 48 geneticin-resistant clones by transient transfection with 1 µg of pUHC13.3. Cells sion starting from nonmuscle cells previously genetically modified. The limits of this type of approach are were split into two 35-mm dishes and tetracycline (Tc) was added into one dish to a final concentration of 2 µg/ also discussed. ml. Luciferase expression was assayed 48 h after trans-MATERIALS AND METHODS fection with Promega luciferase assay system. Protein Plasmids concentration of each cellular lysate was determined according to the Lowry method. The luminometer readings All nucleic acid manipulations were performed following standard protocols (31). Vector pUHD10.3 con-in the luciferase assay divided by the optical density at 750 nm in the protein assay were plotted as the lucifer-Novocastra), an anti-desmin monoclonal antibody (clone DE-R11, Novocastra) and an anti-dystrophin mono-ase activity.
As second step, the best positive clone obtained was clonal antibody Dys1 (anti-dystrophin rod-domain, clone DY4/6D3; Novocastra). expanded and cotransfected with the vectors pUHD10.3 MyoDϳE47, pMRF4Z(300), and pY3 ( Fig. 1 ). At the Cells were fixed with 4% paraformaldehyde for 10 min at 4°C and permeabilized with 0.01% Triton X-100. moment of the transfection, 2 µg/ml Tc was added to the medium. Twenty-four hours after transfection, hy-Cells were then incubated with primary antibodies diluted 1:20 overnight at 4°C. After washing with phos-gromycin B (Boehringer Mannheim) was added to a final concentration of 60 µg/ml and stably transfected col-phate-buffered saline (PBS), cells were incubated with a fluorescein-conjugated goat anti-mouse Ig (1:100 dilu-onies were obtained within 2 weeks.
More than 35 stable resistant clones were isolated, tion) (Jackson ImmunoResearch Laboratories, Inc.) for 1 h at room temperature. Cells were then washed, moun-expanded, and assayed for β-galactosidase expression. For each single clone 1.5 × 10 5 cells were plated on 35-ted in 50% glycerol/PBS (pH 7.4), and observed under a Zeiss Axiophot fluorescence microscope. mm dishes. Twenty-four hours after plating GM was replaced with differentiating medium with or without Tc.
In Vitro X-Gal Histochemistry The X-gal staining was performed in the presence of Tc Stable transfected cells were rinsed twice in PBS, and at 2, 7, and 10 days after Tc removal. The doubling fixed in 0.25% glutaraldehyde, and then incubated in a time of growing and differentiation of stably transfected 0.5 mg/ml solution of X-gal (5-bromo-4-chloro-3-indocells was calculated by plating 1.5 × 10 5 cells of each lyl-β-D-galactopyranoside) for 3 h. The blue cells were cell type on 35-mm dishes in GM and/or in DM in the observed by phase-contrast light microscopy. presence and in the absence of Tc. The cells were counted with an hemocytometer. Data were expressed as Cell Transplantation mean values ± SD.
For in vivo tetracycline-dependent modulation, For the immunofluorescence analysis, 10 4 cells were C57BL/10J wild-type mice were used. Animals were seeded on coverslips and 24 h later GM was replaced immunosuppressed with daily IP injections of 2.5 mg/ with differentiating medium with or without Tc. Immukg FK506 (Fujisawa Pharmaceutical Co. LTD, Osaka, nofluorescence analysis were performed in the presence Japan) from the day before transplantation to the day of Tc and at 3, 7, and 10 days after Tc removal.
of sacrifice. The mice were anesthetized with 10 mg/ml Immunocytochemistry ketamine. The skin was opened to expose the tibialis anterior (TA) muscles and cell injections were per-Immunofluorescence analysis was carried out using the following antibodies: a monoclonal antibody that formed using a glass micropipette (Drummond Scientific, Broomall, PA). To induce muscle regeneration a recognizes slow myosin heavy chain (clone WB-MHCS, small longitudinal cut injury was made with a surgical amplification was not due to contaminating genomic blade before injections. The right TA muscle of all ani-DNA (data not shown). The following primers were mals was injected with 2 × 10 6 transfected cells (susused: pended in a final volume of 10 µl) kept in GM in the LacZ/for: 5′-GTC GTT TAC AAC GTC GTG ACT-3′ presence of Tc, while the left TA muscle was injected LacZ/rev: 5′-ATG GGC GCA TCG TAA CCG TGC-3′ with saline solution. The in vivo myogenic conversion Act/A1: 5′-TCC TGC GTC TGG ACC TGG-3′ was repressed, adding 800 µg/ml doxycycline hydro-Act/A2: 5′-CCA TCT CTT GCT CGA AGT-3′ chloride (dox), a Tc derivative, to drinking water (con-Primers LacZ/for and LacZ/rev amplified a 272-bp taining 1% sucrose) starting 48 h before cell injection.
region of E. coli β-galactosidase gene. The amplification Water containing doxycycline was changed every 3 days was performed during 5 min at 94°C for the first cycle, and mantained in light-protected bottles. denaturation at 94°C for 30 s, annealing at 56°C for 45 Cells were transplanted in 3-month-old mice; 9 out s, extension at 72°C for 45 s for the subsequent 30 cyof 18 animals received dox. Three animals for each cles, and a final extension at 72°C for 10 min. Primers group were killed 5, 7, and 21 days after cell transplan-Act/A1 and Act/A2 generated a 175-bp fragment on the tation. mouse β-actin cDNA. Amplification conditions for β-Tissue Sectioning and Analysis actin were as follows: an initial denaturation at 94°C for Animals were killed by IP pentobarbital administra-5 min was followed by 24 cycles of denaturation at 94°C tion. The TA muscles were removed, frozen in liquid for 30 s, annealing at 65°C (2 cycles) and 55°C (22 cynitrogen-cooled isopentane, and sectioned in transverse cles) for 45 s, extension at 72°C for 30 s, and a final serial sections. β-Galactosidaseand dystrophin-positive extension at 72°C for 10 min. PCR products were elecfibers were counted in 12-µm serial sections obtained trophoresed on a 3.5% agarose gel (1% agarose, 2.5% at every 100 µm throughout the muscle. LacZ-positive NuSeive) and photographed under ultraviolet light after myofibers were counted from adjacent hematoxylin-eostaining with ethidium bromide. sin stained sections and expressed as percentage of the total fibers. The presence of lymphocyte function associ-In Situ Hybridization ated antigen-1 (LFA-1)-positive cells was revealed as Probe Labeling. A 1.3-kb fragment encoding β-gadescribed (13) .
lactosidase was excised from the vector pCMVβ (Clon-In Vivo LacZ Staining tech) after double digestion with EcoRI and NotI. The cDNAs were gel isolated and digoxigenin labeled by The cryostat sections were transferred to gelatinrandom priming according to the manufacturer's instruccoated glass slides. The sections were then fixed by diptions (Dig-DNA labeling and detection kit from Boehping the slides in a cold (4°C) solution of 0.25% glutarringer Mannheim). aldehyde in PBS, pH 7.4, for 15 min, rinsed twice for 5 min in PBS, and stained overnight at 37°C with X-Gal Preparation of Tissue Sections. Briefly, 8-µm cryoat a concentration of 1 mg/ml in 5 mM K 3 Fe(CN), 5 stat sections were cut and transferred onto slides, fixed mM K 4 Fe(CN), 1 mM MgCl 2 in PBS. The slides were in 4% paraformaldehyde in 0.1 M PBS for 10 min at rinsed using PBS and examined microscopically for the room temperature, washed 3 × 4 min in 0.1 M PBS, and presence of β-gal-labeled ("blue") myofibers (9) . treated for 10 min in 0. Immunological Detection System. After hybridiza-variation of the efficacy of Tc-controlled gene expression among different tTA-expressing clones was ob-tion the sections were washed with 2× SSC for 1 h at room temperature, followed by 0.2× SSC for 30 min at served. The levels of inducible expression of the reporter gene obtained in 12 out of 48 clones are shown in Figure  50°C . Slides were next washed for 5 min in buffer 1 (100 maleic acid, 150 mM NaCl, pH 7.5), incubated for 2. We found that the 12 clones fell into three distinct categories: 1 clone did not express the luciferase gene 30 min in buffer 1 containing 0.5% blocking reagent, then incubated for 2 h in 1:2000 dilution of an anti-(clone P10); 4 clones expressed the luciferase gene with an extremely low background in the presence of 2 µg/ digoxigenin antibody conjugated with alkaline phospatase (Boehringer) in buffer 1. After washing for 15 ml Tc and >100-fold higher in the absence of Tc (clones P4, P6, P9, and P11); the other 7 clones had a high min in buffer 1 containing 1 mM levamisole, slides were incubated in color developing solution (35 µl of bromo-maximal luciferase expression in the absence of Tc but the basal expression level was >10-fold higher than the chloro-indolyl phosphate, 45 µl of nitroblue tetrazolium in 10 ml of 100 mM Tris-HCl, pH 9.5, 100 mM NaCl, previous four clones. 50 mM MgCl 2 , and 1% Tween 20) for 18 h at room Myogenic Conversion in Transfected Cells temperature. Reactions were stopped in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8). Slides were washed Clone P4 was selected for its optimal modulation of tTA expression and cotransfected with the vectors pUH-in 100 mM PBS, mounted in aqueous medium, and viewed under a light microscope.
D10.3MyoDϳE47, pMRF4Z(300), and pY3. Preliminary results had shown that cotransfection with only In Situ DNA Fragmentation pMRF4Z(300) and pY3 was not able to induce β-gal The TUNEL (terminal deoxynucleotidyl transferaseexpression in 10 hygromycin B-resistant clones, indicatmediated dUTP-biotin nick end labeling) method was ing a direct specific transactivation of the reporter gene performed for identification of DNA fragmentation. This by MyoD. As parameter of a correct inducible technique was applied using a commercial kit (In Situ MyoDϳE47 gene expression, β-galactosidase positivity Cell Death Detection Kit AP from Boehringer Mannwas evaluated in 36 independent hygromycin B-resistant heim). Briefly, 8-µm cryostat sections were air dried for clones. A wide range of clonal variation in terms of βmore than 1 h and then fixed for 30 min in 4% paragalactosidase positivity in a Tc-dependent manner was formaldehyde in 100 mM PBS, pH 7.4. Cells were perobserved. Forty-eight hours after the Tc removal, 17 out meabilized with 0.1% Triton X-100 in 100 mM sodium of 36 resistance clones showed a β-galactosidase posicitrate, pH 5.2, for 2 min at 4°C and rinsed with PBS.
tivity, but 5 out of 17 presented a homogeneous weak Sections were incubated in a prewarmed humidified positivity also in the presence of Tc. Clones A3, A14 chamber at 37°C for 1 h with 50 µl of a reaction mixture (Fig. 3A, B ) and A25 showed a highly homogenous βcontaining terminal transferase and fluorescein-labeled galactosidase expression 48 h after the Tc removal nucleotides. Sections were then incubated at 37°C for 1 (>95% of blue cells) and this positivity was confirmed h with an alkaline phosphatase-labeled anti-fluorescein after 7 and 10 days. antibody (Boehringer Mannheim). After washing in
The three positive clones were also characterized in PBS, the filtered chromogenic substrate (NBT-X-Phosterms of differentiative potential, keeping the cells in phate) was converted by alkaline phosphatase in a hu-DM and analyzing the expression of muscle-specific midified chamber at room temperature for 15 min.
proteins in the presence and in the absence of Tc (Table  Slides were mounted in glycerol gelatin (Sigma). 1). The clones A3 and A25 showed, after 3 days, a weak positivity for anti-desmin antibody (10% of the cells);
RESULTS
after 10 days about 30% of the cells were desmin posi-Evaluation of tTA Regulatory Protein Activity in tive and about 5% of the cells were dystrophin and myo-NIH-3T3 Transfected Cells sin positive. After 3 days, clone A14 showed positivity for anti-In the first series of experiments, vector pUHD15.1-Neo, encoding tTA regulatory protein and G418 resis-desmin antibody (30% of the cells), which increased in time: after 10 days 65% of the cells were desmin posi-tance genes, was stably introduced into NIH-3T3 cells. The expression levels of tTA were analyzed in 48 inde-tive ( Fig. 3C ). Clone A14 was also positive for dystrophin and for myosin (8% of the cells). pendent geneticin-resistant clones by transient luciferase expression assay performed in the presence and in the In the presence of Tc, none of these clones showed positivity in immunofluorescence detections. As shown absence of tetracycline. The aim was to establish a stable cell line that gives high levels of luciferase activity in Figure 3D , after 10 days of culture in DM without Tc, A14 cells were able to form few myotubes but the when Tc was absent and the lowest possible background expression in the presence of Tc. A wide range of clonal majority of differentiated blue cells remained strictly mononucleated. Analysis of growth curves showed a ± 22.8 fibers/section) for the animals that received dox and 5.7 ± 1.8% (corresponding to 108 ± 34.2 fibers/sec-progressive slowing of proliferation with the withdrawal of tetracycline and the consequent expression of myo-tion) for the animals that did not (p < 0.05, Student ttest). Seven days after cell injection, the percentage of genic factors.
The doubling time of clone A14 cells was determined β-gal-positive muscle fibers was significantly decreased in both groups compared with the results obtained after in the presence and in the absence of Tc in DM. In the presence of Tc, this clone showed the same cellular 5 days (0.3 ± 0.7% corresponding to 6 ± 13.3 fibers/section in the presence of dox and 1.9 ± 1.6% correspond-growth as untransfected NIH-3T3 cells (18.2 ± 1.4 and 18.3 ± 1.9 h, respectively). Forty-eight hours after the ing to 36 ± 30.4 fibers/section when dox was absent). Figure 5B shows the incision area in which a cluster withdrawal of Tc the doubling time was 28.7 ± 2.5 h; after 4 days it was 36.2 ± 2.7 h. Doubling time remained of β-gal-positive myofibers are aligned within regenerating fibers with apparently normal structures. The pres-stationary in time (8-10 days after withdrawal of Tc). Similar results were obtained with clones A3 and A25.
ence of β-gal-positive myofibers was confirmed in adjacent sections by in situ hybridization method (Fig. 5C ). To determine the stability of the inducible system, clone A14 cells were maintained in GM for 4 months
The lacZ expression pattern observed by in situ hybridization using a digoxigenin-labeled probe was identical in the presence of Tc; β-galactosidase expression was analyzed after a total of 30 passages. Total RNA was to the X-gal staining pattern. Only in a few cases was LacZ mRNA expressed in β-gal-negative myofibers. extracted from cells maintained in DM for 3 days in the presence and in the absence of Tc, and LacZ expression
The β-gal-positive fibers were found at the site of injections and along the track of the incision area. was evaluated by the RT-PCR method. A high level of inducibility was observed (Fig. 4) . The hygromycin B-Mature peripherally nucleated myofibers were observed 21 days after transplantation within injected ar-resistant clone A14 was designated for in vivo experiments.
eas. No β-gal-positive fibers were detected at this time point.
Dox-Dependent Induction of Myogenesis In Vivo
Apoptotic Myonuclei Detected by In Situ DNA Labeling Mice were sacrificed 5, 7, and 21 days after transplantation of clone A14 cells. The in vivo MyoD-medi-To provide more information about the lack of X-gal expression, transplanted TA muscles were tested by the ated myogenic conversion and muscle fusion in the area of cell injection were analyzed by hematoxylin-eosin TUNEL method. A minimal positive reaction was detected in nuclei of doxycycline-treated muscles while a ( Fig. 5A ) and X-gal (Fig. 5B) staining. This area was about 300 µm 2 and contained regenerating myofibers large number of myonuclei became positive in muscles that did not received dox (Fig. 6A, C) . The peak concen-and cellular infiltrations as confirmed by the presence of LFA-1-positive cells. The cell infiltration decreased tration of apoptotic nuclei was observed in mice sacrificed 7 days after cell injection. rapidly 7 days after transplantation and was not significantly different from the left TA muscles treated with At this time, the mean value of positive myonuclei observed in the animals that did not received dox was saline solution.
To detect β-gal-positive myofibers, 25 sections were 44.3 ± 8.1 apoptotic nuclei/mm 2 while in the animals treated with dox the mean was 12.5 ± 4.1 apoptotic nu-analyzed for each muscle. No β-gal-positive myofibers were observed in regenerating muscles injected with sa-clei/mm 2 . In the left TA muscles injected with a saline solution, a mean value of 11.2 ± 2.6 apoptotic nuclei/ line solution (data not shown). Fibers of the same section exhibited different levels of LacZ activity, some fi-mm 2 was detected. The difference in apoptotic nuclei between dox-and non-dox-treated muscles was statisti-bers being more intensely stained than others. Five days after transplantation the percentage of β-galactosidasecally significant (p < 0.05, Student t-test). The TA muscles from mice not treated with dox showed foci of in-positive myofibers was 0.8 ± 1.2% (corresponding to 15 flammation in the injected areas with the presence of they are easily obtained in significant quantities and can infiltrating LFA-1-positive cells (Fig. 6B, D) , macrobe stably converted into myoblasts by transfection with phages, other mononuclear cells, and small regenerating a MyoD construct, thus offering a potential source of myofibers with centrally located myonuclei. Apoptotic cells viable for ex vivo gene transfer. nuclei were observed in these areas of the muscle but
In this work, we explored this possible alternative could not be clearly identified as myonuclei. Those nutherapeutic strategy for primary myopathies such as DMD. clei were not included in counts.
The myoblast conversion of the murine NIH-3T3 cell Many apoptotic nuclei were localized at the periphery line was obtained through the expression of inducible of the injection site and belonged to LFA-1-negative MyoD. The use of a system in which the time of myocells. A few muscle fibers that displayed histological genic conversion is pharmacologically regulated allowed signs of regeneration, such as central nuclei, were also us to overcome the cell growth reduction due to the inobserved to contain apoptotic nuclei.
duction of the myogenic determination program. The transactivation of a MRF4-driven reporter gene was DISCUSSION used to verify the MyoD expression, taking advantage The lack of dystrophin causes Duchenne muscular of the physiological interaction between MyoD and the dystrophy, a progressive muscle fiber degenerative dispromoter/enhancer complex of MRF4. The myogenic ease resulting in muscle weakness and premature death. phenotype of converted fibroblasts was assayed by im-Presently there is no treatment for DMD, but gene remunohistochemical characterization of muscle-specific placement is considered as an attractive potential therproteins. apy. The expression of functional dystrophin into mus-In general, studies using inducible expression in stacle fibers was obtained by myoblast-mediated gene ble cell lines overcome some of the inherent limitations transfer (14,24,37). Injected myoblasts are able to cross of transient transfection studies, including variable transbasal lamina and become an integral part of mature host fection efficiencies and the long-term stability of the muscle fibers (2). Ex vivo gene therapy based on autolosystem. However, with most regulated expression sysgous transplantation of genetically modified myoblasts tems, inactivation is usually not complete and the inis limited by their low proliferative capacity (due to ducers (i.e., heat shock, metal ions, and hormones) often premature senescence). Nonmuscle cells, such as fibrocan activate endogenous promoters or affect other cellublasts, amnyocites, or chorionic-villus cells, are not encumbered by exhaustion of their proliferating potential; lar processes. The ability to control the expression of a cloned gene in a homogeneous population of stably transfected cells provides a powerful tool for studying protein function. An alternative approach is to use prokaryotic promoters and their activators such as the tetracycline-regulated gene expression system derived from the E. coli tetracycline resistance operon. The transactivator protein (tTA) stimulates transcription from a promoter containing tetracycline operator sequences (tetO), but it is prevented from interacting with the tetO by micromolar concentrations of tetracycline (11). This system allows high levels of expression in the activated state and essentially complete inactivation by tetracycline or its derivatives, such as doxycycline, that are not toxic for eukaryotic cells and animals (29) . In our model the tetracycline-inducible system permits an examination of phenotypic and morphological changes that are associated with changes in the synthesis of MyoD protein.
In order to establish an optimal controllable system, the cells used for in vitro and in vivo experiments are the result of two sequential transfections and two different screening steps. Initially, starting from NIH-3T3 cell line, a careful selection of the clones expressing tTA was performed by transient transfection with the reporter gene luciferase linked to a tTA -responsive promoter. Then the tTA-expressing cell line (clone P4) was used to establish the stable cell line expressing MyoDϳE47 cDNA. Isolated clones had been screened for their ability to express the gene product at a high level and in a regulated manner by comparing expression obtained in the presence and in the absence of tetracycline. The correct inducible activation of MyoD is revealed by the expression of the reporter gene β-galactosidase. We observed a wide range of clonal variation in terms of βgal positivity, due to different numbers and several integration sites of the plasmids into the cells. The screening steps for obtaining resistance clones allowed us to isolate one clone (clone A14) in which MyoD expression was tightly regulated after Tc removal and with a high homogenous pattern (more than 95% of the cells). After integration in NIH-3T3 cells, these exogenous genes remained unmodified and were stably expressed over time.
We also characterized the forced myogenic conver- antibodies. We observed a lower positivity for muscle proteins in spite of the very high level of β-gal positivity. The heterogeneous efficiency of MyoD-driven myogenic conversion has been demonstrated. Several studies have shown how the efficiency of myogenic conversion of nonmuscle cells is directly related to the relationship with myoblast lineage (5). The potential for myogenic conversion is high in fibroblasts in which ter-the activation of forced myogenic process. In spite of the expression of specific muscle proteins, we observed minal differentiation and myotube formation can be easily observed and lower in other cells types (chon-a low in vitro myotube formation; cells grown in DM appeared to become aligned, but the majority of differ-droblasts, hepatocytes, and amnioblasts), which are refractory to myogenic conversion in spite of exogenous entiated cells remained strictly mononucleated, failing to fuse in multinucleated cells. This type of phenotype has MyoD expression (33) . Also, the histological origin plays a role in the potential for myogenic conversion. A been recently described as characteristic of NIH-3T3 cells converted by exogenous expression of MyoD fam-study that compared the relative efficiency of MyoD to induce myogenic conversion of human and murine pri-ily members (30) . Analysis of muscle regulatory and structural gene expression failed to provide an explana-mary fibroblasts isolated from different tissues demonstrated that fibroblasts from the dermis converted better tion for the in vitro fusion defectiveness. A possible cause of this phenotype has been attributed to the failure than fibroblasts from skeletal muscles, whereas in the same study adherent cells from bone marrow presented to accumulate the transcripts encoding muscle-specific isoforms of the β1D integrin subunit and the transcrip-the lowest propensity to myogenic conversion (20) . Conversion efficiency declined with age and murine fi-tional factor MEF2-D1b2. However, the dissociation of terminal differentiation and myogenic conversion also broblasts seemed to convert better than their human counterparts.
has been previously observed in myoblasts in particular conditions, such as the C 2 C 12 cells transformed by the v-In the absence of tetracycline, clone A14 cells performed a permanent withdrawal from cell cycle as shown myc oncogene (6) . The mechanisms involved in the fusion of myotubes are still poorly defined. Our data con-in the analysis of growth curves. These data confirmed firm the suggestion that myotube formation can be apoptotic nuclei in the group of animals not treated with doxycycline compared with treated muscles, suggesting genetically dissociated from MyoD-dependent transcriptional activation; muscle-specific gene expression can be the possibility that apoptotic events occurred more frequently in the forcedly converted myogenic cells. Never-considered necessary but not sufficient to commit differentiated myocytes to myotubes. theless, the positivity to DNA fragmentation was mainly observed inside the site of cellular implantation where Another primary goal of this study was to verify whether tetracycline-dependent regulation could be a high number of LFA-1-positive infiltrates and small regenerating myofibers with centrally located myonuclei demonstrated in an experimental model relevant to gene therapy. In vivo applications of the tetracycline-induc-were present. It is likely that cytokines locally secreted by inflammatory cells may induce programmed cell ible system have been documented in transgenic mice. Long-term expression has been described following the death. The positive apoptotic myonuclei were also localized near the site of injection in peripherally located transplantation of retrovirally transduced primary cells in animals (4). In addition to the suitable control system, myofibers. This implies that the apoptotic events observed in animals not treated may be considered as a the successful transplantation of engineered cells required an excellent survival of the implanted cells and direct consequence of the in vivo-induced myogenic conversion. Our data are in agreement with the evidence the fusion of forced converted myoblasts with host muscle fibers.
that MyoD-positive cells (i.e., activated satellite cells and proliferating myoblasts in culture) are able to un-Selected derivates of NIH-3T3 cells (clone A14) were transplanted in skeletal muscles of normal mice. dergo apoptosis (22, 38) .
In conclusion, we have focused on two different as-Five days after transplantation, a negligible β-galactosidase gene expression was observed in TA muscles when pects. First was the possibility to regulate the myogenic conversion of nonmuscle cells such as fibroblasts in a animals were treated with doxycycline in the drinking water. However, a statistically significant increase of X-tetracycline-dependent manner; the feasibility of the system has been demonstrated also through in vivo ex-gal-positive regenerating myofibers was found in muscle cross sections from normal mice not treated with doxy-periments. Second, we have shown one of the most important limits of ex vivo gene therapy of primary myop-cycline, suggesting the possibility of an in vivo-inducible MyoD-mediated myogenic conversion. The pres-athies based on the forced conversion of fibroblast to myoblasts. There is for that situation very poor long-ence of β-galactosidase mRNA detected by in situ hybridization technique has shown the same tissue local-term survival of a high number of donor cells transplanted into the muscle of the hosts. In particular, we ization, supporting the specificity of X-gal staining. The blue cells were localized as clusters of lacZ-positive have examined the possibility that apoptotic events might play a role in the death of transplanted cells. This cells around the site of injection and along the track of the incision area, confirming the minimal cellular move-problem will have to be further addressed in the perspective of the cell-mediated gene therapy of inherited mus-ment due to their limited migratory capacity in the host muscle. The number of positive blue cells decreased sig-cle disorders. nificantly 7 days after transplantation and disappeared
